It's been 30 years since a new drug to delay kidney disease progression in adults with type 1 diabetes was successful in a clinical trial -- the last being the ACE inhibitor captopril in 1993 -- noted ...

Recently published Chronic Kidney Disease Market Insights report includes a comprehensive understanding of current treatment practices, chronic kidney disease emerging drugs, market share of ...

Low-dose zoledronic acid appeared safe among older patients with hip fracture and advanced chronic kidney disease.

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

A new study published in the Journal of American Medical Association showed that the severity of chronic kidney disease (CKD) ...

Some of this was on display as Ami Bhatt, Chief Innovation Officer (CIO) at the American College of Cardiology, interviewed ...

Both approaches identified hemoglobin as one of the most significant predictors of CKD risk. Additional top-ranked features included blood urea, sodium levels, red blood cell count, potassium, and ...

Chronic kidney disease is associated with a significantly increased risk for workforce detachment among adults of working age, a Danish study finds.

Background The epidemiology and long-term healthcare utilisation associated with chronic kidney disease (CKD) among those ...

Citing the study, Wu said that CKD progression leads to a near exponential increase in medical burden and greenhouse gas ...

Bethenny Frankel revealed her chronic kidney disease has progressed to Stage 3 just weeks after she was initially diagnosed with stage 2: “I’m not going to be quite alarmed yet.” ...

CHRONIC Kidney Disease (CKD) in the Philippines, “especially among the youth,” is rising at an alarming rate, and could lead to a public health crisis in the country, Senator Mark Villar has warned.